Загрузка...
Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience
OBJECTIVE: Data related to the safety and tolerability of treatments for pediatric type 2 diabetes are limited. The TODAY clinical trial assessed severe adverse events (SAEs) and targeted nonsevere adverse events (AEs) before and after treatment failure, which was the primary outcome (PO). RESEARCH...
Сохранить в:
| Формат: | Artigo |
|---|---|
| Язык: | Inglês |
| Опубликовано: |
American Diabetes Association
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3661822/ https://ncbi.nlm.nih.gov/pubmed/23704676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2390 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|